Cochlear announces launch of new cochlear implant
Medical device manufacturer Cochlear (ASX: COH) has announced the launch of its latest Nucleus Profile Plus Series cochlear implant, and its approval for sale in the United States by the FDA. In a series of ASX announcements today the Sydney company announced commercial availability for the implant in Germany with other European countries to follow.…